Skip to content

Clinical trials

Hypersensitivity trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Phase: Not applicable Country / region: China Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20161
20181
20191
20212
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status2
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Guangzhou Institute of Respiratory Disease2
Société des Produits Nestlé (SPN)2
Children's Hospital of Fudan University1
Fujian Cancer Hospital1
Guangdong Provincial People's Hospital1
Peking University1
Peking University Cancer Hospital & Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity9
Dermatitis, Atopic2
Anxiety Disorders1
Asthma1
Bronchial Hyperreactivity1
Esophageal Squamous Cell Carcinoma1
Inflammation1
Milk Hypersensitivity1
Myocardial Infarction1
Obesity1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.